Also listed on Acea Biosciences, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Feb 5, 2033 · High confidence
20-year base term ends Oct 22, 2032
Held by Agilent Technologies, Inc.
Filed Oct 22, 2012 as application 13/657,845 · Granted Feb 14, 2017
Base term plus 106 days of patent term adjustment (USPTO delay)
Today
2012
2033
Clock starts
Oct 22, 2012
Oct 22, 2012
Term ends
Feb 5, 2033
Feb 5, 2033
Granted
Feb 14, 2017
Feb 14, 2017
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
106
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 106 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 22, 2012, when this application, 13/657,845, was filed | Oct 22, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +106 days, USPTO patent term adjustment record | Feb 5, 2033 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 5, 2033 | High confidence |
This family
| US 9,568,423 | this patent Feb 2033 | Feb 2033 |
| US 10,648,913 | In force Oct 2032 | Oct 2032 |
| US 11,287,379 | In force Oct 2032 | Oct 2032 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 30, 2016 Reel 39909, frame 440 | Li, Nan; Wu, Jian; Chen, Ye; Wang, Tianxing; Wang, Xiaobo | Acea Biosciences, Inc. | Assignment of Assignor's Interest |
| Feb 25, 2021 Reel 55409, frame 874 | Acea Biosciences, Inc. | Agilent Technologies, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2033
Term ends Feb 5, 2033. Maintenance fees still fall due before then
Note
The 106 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
55
later US patents cite this one
That is top 10% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.